Chemical Structure : Selitrectinib
CAS No.: 2097002-61-2
Catalog No.: PC-60901Not For Human Use, Lab Use Only.
LOXO-195 (Selitrectinib, LOXO195) is a potent, selective, next-generation Trk tyrosine kinase inhibitor with IC50 of 0.6 nM and <2.5 nM for WT TrkA and WT TrKC, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $78 | In stock | |
10 mg | $118 | In stock | |
25 mg | $218 | In stock | |
50 mg | $368 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LOXO-195 (Selitrectinib, LOXO195) is a potent, selective, next-generation Trk tyrosine kinase inhibitor with IC50 of 0.6 nM and <2.5 nM for WT TrkA and WT TrKC, respectively.
LOXO-195 also diplays high potentcy against mutant TrkA G595R, TrkA G667C, TrkC G623R and TrkC G696A with IC50 of 2.0, 9.8, 2.3 and <2.5 nM, respectively.
LOXO-195 overcomes acquired resistance mediated by recurrent kinase domain (solvent front and xDFG) mutations identified in multiple patients.
M.Wt | 380.427 | |
Formula | C20H21FN6O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo[1,5-a]pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one |
1. Drilon A, et al. Cancer Discov. 2017 Sep;7(9):963-972.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright